Strategy Driven

JUNE 10, 2020

To remain relevant and record notable growth in the pharmaceutical industry, companies need to make productivity enhancement a priority. well, driving productivity in a pharmaceutical company involves seeking more efficient processes, equipment, and recruitment strategies. More so, it is advisable that pharmaceutical companies keep track of the Standard Operating Procedures relevant to their industry and consistently match their current processes to what is expected.

Pharmaceuticals 67

Pharmaceuticals Efficiency Quality Tips 67

HR Digest

FEBRUARY 8, 2019

Mgr Business Process Analyst - Teva Pharmaceuticals - Bombay, NY. The post Mgr Business Process Analyst – Teva Pharmaceuticals – Bombay, NY appeared first on The HR Digest. HR Jobs. The Corporate Systems Analyst is responsible for the successful management of existing core HR systems and related processes end-to-end from understanding. From Adicio - Fri, 08 Feb 2019 13:44:16 GMT - View all Bombay, NY jobs.

Pharmaceuticals 28

Pharmaceuticals System Process Succession 28

HR Digest

FEBRUARY 5, 2019

Mgr HR Shared Services - 2814 - Teva Pharmaceuticals - Bombay, NY. The post Mgr HR Shared Services – 2814 – Teva Pharmaceuticals – Bombay, NY appeared first on The HR Digest. HR Jobs. HR Operations and Services. Associate Director- HR Shared Services. Building relationship with site HR and Business. 8-10 years of work experience in HR Shared. From Adicio - Tue, 05 Feb 2019 19:55:55 GMT - View all Bombay, NY jobs.

Pharmaceuticals 28

Pharmaceuticals Operations 28

Harvard Business

SEPTEMBER 28, 2020

Sponsor content from Indegene. Innovation Customer service Technology Sponsor Content

Pharmaceuticals 36

Pharmaceuticals Content Industry Technology 36

Harvard Business

MARCH 11, 2018

That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The biggest change for pharma in Japan was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act—for pharmaceutical and medical devices. Older people need more medicine.

Pharmaceuticals 30

Pharmaceuticals Incubator Health Care Content 30

Harvard Business

SEPTEMBER 23, 2020

Race Pharmaceuticals Digital ArticleHow scientific institutions can address systemic racism.

System 58

System Pharmaceuticals Article 58

Harvard Business

AUGUST 18, 2020

Leadership & Managing people Pharmaceuticals Healthcare Digital ArticleThree strategies to stay laser focused on the path to a cure.

Strategy 58

Strategy Pharmaceuticals Article Management 58

Harvard Business

OCTOBER 18, 2019

Technology Analytics Regulation Healthcare Pharmaceuticals Technology Digital ArticleA few key obstacles and how to overcome them.

Health Care 44

Health Care How To Pharmaceuticals Technology 44

Harvard Business

MAY 2, 2019

Research & development Technology Pharmaceuticals Healthcare Technology Digital ArticleIt will help patients and bring new treatments to market faster.

Marketing 44

Marketing Pharmaceuticals Technology Article 44

Harvard Business

JUNE 30, 2020

Technology Healthcare Pharmaceuticals Digital ArticleIt offers enormous benefits — but can’t replace in-person visits.

Pharmaceuticals 28

Pharmaceuticals Technology Article 28

Harvard Business

MARCH 6, 2020

Strategy Research & development Healthcare Pharmaceuticals Technology Digital ArticleA study of nearly 100 organizations.

Organization 28

Organization Strategy Pharmaceuticals Technology 28

Harvard Business

JUNE 12, 2020

Technology Analytics Healthcare Technology Pharmaceuticals Government Digital ArticleWe need to shift from reactive to preventative care.

Pharmaceuticals 28

Pharmaceuticals Technology Article 28

Harvard Business Review

SEPTEMBER 22, 2015

As the ire over high prescription drug prices in the United States escalates , it’s easy to blame pharmaceutical companies. But pharmaceutical companies aren’t to blame. Over the last five years, returns for the S&P Pharmaceuticals Select Industry Index have been virtually double that of the S&P 500 (roughly 24% vs. 12% annually). In fact, Congress has explicitly prohibited Medicare from negotiating drug prices with pharmaceutical companies.

Pharmaceuticals 12

Pharmaceuticals Budgeting Insurance Price 12

First Friday Book Synopsis

JUNE 30, 2013

Bob''s blog entries Abercrombie & Fitch in retail Better before cheaper: Compete on differentiators other than price Deloitte Heartland Express in trucking Maytag in appliances Merck in the pharmaceutical industry Michael E. In search of an answer that could be supported with empirical proof, Michael E. Raynor and Mumtaz Ahmed, along with their team of researchers at Deloitte, embarked on a daunting quest.

Company 73

Company Travel Cost Pharmaceuticals 73

First Friday Book Synopsis

MARCH 21, 2012

Bob's blog entries (MD) Apollo Computer Baltimore Bluefin Labs Bowstreet Cincinnati Children’s Hospital Frank Moss Haifa IBM Infinity Pharmaceuticals Lotus Development MIT University Princeton University the Mayo Clinic the MIT Media Lab the Practice of New Media Medicine The Sorcerers and Their Apprentices: How the Digital Magicians of the MIT Media Lab Are Creating the Innovative Technologies That Will Transform Our Lives Tivoli Systems Stellar Computer Twitter

Entrepreneur 77

Entrepreneur Pharmaceuticals Mayo Industry 77

First Friday Book Synopsis

MAY 11, 2011

Value Migration: How to Think Several Moves Ahead of the Competition Adrian J. Slywotzky Harvard Business Press (1995) Note: I recently re-read this book before beginning to formulate questions for an interview of Skywotsky. With all due respect to current business bestsellers, none offers more and better insights of immediate and substantial value. Mastering an [.].

Slywotzky 77

Slywotzky Review Pharmaceuticals Books 77

Harvard Business

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. The pharmaceuticals industry has seen an explosion in the amount of available data beyond that collected from traditional, tightly controlled clinical trial environments. Analytics Data Research & development Healthcare Pharmaceuticals Digital Article

Incubator 47

Incubator Biotechnology Health Care Compliance 47

Harvard Business

FEBRUARY 26, 2018

Regeneratives are pharmaceutical cell therapy products that replace or restore cells and tissues lost to disease or aging. “To be able to do that, they need to entice companies to come to Japan, and they need to entice their own pharmaceutical companies to license in and obtain the best.” It includes a designation system that promotes R&D in Japan aimed at early practical application for innovative pharmaceutical products, medical devices, and regenerative medicines.

Licensing 30

Licensing Content Guidelines Trends 30

Harvard Business

NOVEMBER 12, 2018

Innovation Business models Entrepreneurship Healthcare Pharmaceuticals Technology Digital ArticleTEK IMAGE/SCIENCE PHOTO LIBRARY/Getty Images. When the FDA issued its first approval for a gene therapy for an inherited disease nearly a year ago—a cure for a type of blindness—it was heralded as breakthrough, a moment decades in the making.

Business Model 44

Business Model Insurance Bond Cost 44

Harvard Business

JUNE 9, 2017

In some states, accepting a cup of coffee from a pharmaceutical company must be reported, so “education” over lavish meals or in resort settings has largely receded. Guided by a refreshed ethical framework, pharmaceutical companies, in partnership with researchers and clinicians, can help accelerate the spread of knowledge of new clinical science, which now is notoriously slow. Ethics Research & development Government Healthcare Pharmaceuticals Digital Article

Conflict of Interest 47

Conflict of Interest Policies Industry Committee 47

Harvard Business

JULY 2, 2019

A study of pharmaceutical firms finds that it leads to valuable collaborations. Research & development Joint ventures Competition Digital Article

Pharmaceuticals 44

Pharmaceuticals Innovation Article Development 44

Harvard Business

JUNE 13, 2016

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain. One place to start might be a fresh look at the incentive compensation structure in the pharmaceutical industry. Sales Marketing Pharmaceuticals Digital Article

Incentives 44

Incentives Crisis Insurance Metrics 44

Harvard Business

AUGUST 3, 2016

This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. What makes our study unique is that we compared firms’ innovation activities not only before and after acquisitions, but we also compared those merging companies to firms in similar pharmaceutical markets without merger activities. And so pharmaceutical firms appear to be benefitting from regulators’ incomplete decision process.

Innovation 44

Innovation Price Incentives Company 44

Harvard Business

JANUARY 12, 2017

Organizations collecting patient data — including academic medical centers, foundations that sponsor cancer research, and pharmaceutical companies — must first identify the needs, pains, hopes, expectations, and behaviors of each person living with cancer. Marketing Research & development Social platforms Non-profit Healthcare Pharmaceuticals Digital Article

Storytelling 47

Storytelling Health Care Discount Loyalty 47

leaderCommunicator

APRIL 8, 2019

Whether you are a highly matrixed, multisite healthcare system undergoing a merger, or global pharmaceutical or medical device company expanding its portfolio, the common thread is complexity. Even with such rampant murkiness, one thing is very clear: good employee communication can turn strategy into action and keep employees focused on what matters, help them navigate through the change, and minimize disruption that can slow productivity, performance and engagement.

Pharmaceuticals 75

Pharmaceuticals Globalization System Strategy 75

Harvard Business

NOVEMBER 1, 2018

Organizational culture Gender Policy Corporate governance Healthcare Pharmaceuticals Digital ArticleCarmen Martínez Torrón/Getty Images. Many factors make an organization prone to sexual harassment: a hierarchical structure, a male-dominated environment, and a climate that tolerates transgressions — particularly when they are committed by those with power. Medicine has all three of these elements.

Health Care 28

Health Care Report Compliance Reputation 28

Harvard Business

JUNE 21, 2017

Shared value Research & development Collaboration Healthcare Pharmaceuticals Digital ArticleIt is well understood that achieving the full potential of precision medicine for all cancer patients depends on the sharing of patients’ genomic and molecular data and clinical information.

Metrics 30

Metrics Health Care Organization Education 30

Strategy Driven

OCTOBER 30, 2019

StrategyDriven Editorial Perspective Automotive Industry business management Hi-Tech Medical and Pharmaceutical Industry strategydrivenTo some degree, every single industry is shaping the world we live in. After all, without even the smallest business, the world would be a slightly different place. However, this can be a pedantic way of looking at things.

Industry 10

Industry Travel Ethics Trends 10

Great Leadership By Dan

AUGUST 27, 2020

Molinaro has helped create one of the leading brands in the Human Capital industry, working in several key sectors including energy, pharmaceutical, professional services, technology, financial services, and the public sector.

Leadership 264

Leadership Pharmaceuticals Uncertainty Human Capital 264

thoughtLEADERS, LLC

JANUARY 13, 2020

Ahmed, the Vice President for Manufacturing in a large pharmaceutical company could hardly sit still as frustration boiled over. When leaders take on more responsibility it’s important not to lose all the skills and qualities that got them there. Today’s post is by Graeme Findlay, author of Evolve (CLICK HERE to get your copy).

360-Degree Feedback 50

360-Degree Feedback Pharmaceuticals Skills Executive Coaching 50

Harvard Business Review

JULY 23, 2015

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. The rationale is simple and elegant: A company with experience selling pharmaceutical products should be able to successfully and profitably sell its large customers (health plans, delivery systems, and governments) other health care offerings.

Health Care 12

Health Care Committee Industry Company 12

Lead Change Blog

SEPTEMBER 26, 2016

Valeant/Philidor pharmaceutical companies. And this list doesn’t include those who really didn’t apologize like Sepp Blatter, former FIFA president; Martin Shkreli, former CEO, Turing Pharmaceuticals; or recently ousted Pennsylvania Attorney General Kathleen Kane). Last week the CEO of Wells Fargo, a bank that’s been around since 1852, testified before Congress about the egregious wrong-doings committed by employees in his company all in the name of meeting sales goals.

Golden Parachute 298

Golden Parachute Pharmaceuticals Ryan Banking 298

Harvard Business

FEBRUARY 3, 2017

The business model of research-based pharmaceutical companies is under significant pressure. However, it also reflects stronger pressures to lower medicine costs in traditional pharmaceutical markets. citizens than pharmaceuticals (the sector’s worst showing in 16 years). And it is the first topic of the provisional standard for the pharmaceutical sector produced by the Sustainability Accounting Standards Board.

Reputation 47

Reputation Price Compliance Business Model 47

Harvard Business

APRIL 6, 2017

The 1984 Drug Price Competition and Patent Term Restoration Act gave pharmaceutical companies exclusive protections for innovating a new drug. ” By selling a drug they’re already making under a different name, pharmaceutical firms are effectively extending their monopoly for another six months. Another way pharmaceutical firms are thwarting generics is by restricting access to samples for testing. Regulation Branding Manufacturing Pharmaceuticals Digital Article

System 49

System Sample Tactics Quality 49

Strategy Driven

DECEMBER 1, 2020

The discovery and development of pharmaceuticals is an expensive and time-consuming process. AI and machine learning are technologies which come with many promises.

Wireless 65

Wireless Pharmaceuticals Technology Industry 65

Great Leadership By Dan

OCTOBER 1, 2020

Based on these criteria, I see pharmaceutical companies as primarily profit-driven. Guest post from S. Chris Edmonds : Is your company primarily power-, profit-, or purpose-driven?

Blanchard 186

Blanchard Pharmaceuticals Company Retail 186

Harvard Business

JULY 6, 2016

For 78-year-old Tony, 3,4 DAP — which can be obtained at low cost from compounding pharmacies or for free through a compassionate-use program supported by a small privately held company, Jacobus Pharmaceuticals — is a lifesaver. Pharmaceutical companies traditionally invest heavily in research and development. Ionis Pharmaceutical has been especially successful in creating a pipeline of these drugs, such as Nusinersen, a promising therapy for spinal muscular atrophy.

Price 44

Price Health Care Proposal Mayo 44

Harvard Business

MAY 15, 2019

Youngme, Felix, and Mihir discuss whether pharmaceutical players like the Sackler family members should be held accountable for the current opioid crisis. They then debate the growing reliance on artificial intelligence bots by human resource departments in the job screening process. Social responsibility Economics & Society Technology Audio

Pharmaceuticals 30

Pharmaceuticals Human Resources Resources Process 30

Lead Change Blog

OCTOBER 18, 2012

COO and CMO, To Be a Woman CRO (Chief Relationship Officer), CEO ConnectionLisa Petrilli's corporate leadership experience includes running a $750 million medication delivery business and a team of marketers while negotiating global licensing, commercialization and co-marketing contracts with pharmaceutical companies.

COO 249

COO PR Pharmaceuticals Licensing 249

LDRLB

AUGUST 24, 2011

It’s been over half a year since a potentially landmark event occurred in the pharmaceutical industry. I spent five years in the pharmaceutical industry, and had the chance to talk to many GSK representatives when the measures were announced. Most believed it was just a public relations stunt to try and present themselves as the “good guys” in pharmaceutical marketing – focused solely on customer needs.

Pharmaceuticals 80

Pharmaceuticals Incentives Insurance Metrics 80

Aspire-CS

JANUARY 8, 2019

In the formative stages of my career I was a Human Resources generalist for a large Pharmaceutical company. Photo credit: 123RF. As an avowed problem-solver I got frustrated when people came to me with drawn-out tales of workplace woe that I just couldn’t solve for them. I learned to manage my anxiety by using a question after they told their story that is so flexible and useful that I still use it, or a variation today. And it’s a question you can use as well.

Pharmaceuticals 158

Pharmaceuticals Human Resources Career Resources 158

First Friday Book Synopsis

APRIL 29, 2015

Primeast works primarily in the oil and gas, power, pharmaceutical and […]. Clive Wilson is a writer, speaker, facilitator and business coach. He is a director of Primeast, a learning and development company based in the beautiful town of Harrogate in the county of North Yorkshire in the United Kingdom, some 220 miles north of London.

Pharmaceuticals 92

Pharmaceuticals How To Collins Wilde 92

Lead Change Blog

SEPTEMBER 7, 2018

These industries include transportation, restaurant, hospitality, manufacturing, pharmaceutical, and entertainment. Whether you lead teams of five, 25 or 105,000 people, the level of trust you give goes a long way to determining the success of your organization. Trust is one of the top five leadership “blind spots” our research has shown to be an inhibitor of engagement and performance. You and your organization want and need to deliver great service to differentiate yourself.

Guidelines 284

Guidelines Pharmaceuticals Policies Transportation 284